These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36403020)

  • 21. Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk children.
    Gordon O; Brosnan MK; Yoon S; Jung D; Littlefield K; Ganesan A; Caputo CA; Li M; Morgenlander WR; Henson SN; Ordonez AA; De Jesus P; Tucker EW; Peart Akindele N; Ma Z; Wilson J; Ruiz-Bedoya CA; Younger MEM; Bloch EM; Shoham S; Sullivan D; Tobian AA; Cooke KR; Larman B; Gobburu JV; Casadevall A; Pekosz A; Lederman HM; Klein SL; Jain SK
    JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34855624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
    Balcells ME; Rojas L; Le Corre N; Martínez-Valdebenito C; Ceballos ME; Ferrés M; Chang M; Vizcaya C; Mondaca S; Huete Á; Castro R; Sarmiento M; Villarroel L; Pizarro A; Ross P; Santander J; Lara B; Ferrada M; Vargas-Salas S; Beltrán-Pavez C; Soto-Rifo R; Valiente-Echeverría F; Caglevic C; Mahave M; Selman C; Gazitúa R; Briones JL; Villarroel-Espindola F; Balmaceda C; Espinoza MA; Pereira J; Nervi B
    PLoS Med; 2021 Mar; 18(3):e1003415. PubMed ID: 33657114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients.
    Misset B; Piagnerelli M; Hoste E; Dardenne N; Grimaldi D; Michaux I; De Waele E; Dumoulin A; Jorens PG; van der Hauwaert E; Vallot F; Lamote S; Swinnen W; De Schryver N; Fraipont V; de Mey N; Dauby N; Layios N; Mesland JB; Meyfroidt G; Moutschen M; Compernolle V; Gothot A; Desmecht D; Taveira da Silva Pereira MI; Garigliany M; Najdovski T; Bertrand A; Donneau AF; Laterre PF
    N Engl J Med; 2023 Oct; 389(17):1590-1600. PubMed ID: 37889107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.
    Simonovich VA; Burgos Pratx LD; Scibona P; Beruto MV; Vallone MG; Vázquez C; Savoy N; Giunta DH; Pérez LG; Sánchez MDL; Gamarnik AV; Ojeda DS; Santoro DM; Camino PJ; Antelo S; Rainero K; Vidiella GP; Miyazaki EA; Cornistein W; Trabadelo OA; Ross FM; Spotti M; Funtowicz G; Scordo WE; Losso MH; Ferniot I; Pardo PE; Rodriguez E; Rucci P; Pasquali J; Fuentes NA; Esperatti M; Speroni GA; Nannini EC; Matteaccio A; Michelangelo HG; Follmann D; Lane HC; Belloso WH;
    N Engl J Med; 2021 Feb; 384(7):619-629. PubMed ID: 33232588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study.
    Rojas M; Rodríguez Y; Hernández JC; Díaz-Coronado JC; Vergara JAD; Vélez VP; Mancilla JP; Araujo I; Yepes JT; Ricaurte OB; Pardo-Oviedo JM; Monsalve DM; Acosta-Ampudia Y; Ramírez-Santana C; García PG; Landinez LA; Correales LD; Grass JS; Pérez CR; López GS; Mateus N; Mancera L; Devia RR; Orjuela JE; Parra-Moreno CR; Buitrago AA; Ordoñez IE; Osorio CF; Ballesteros N; Patiño LH; Castañeda S; Muñoz M; Ramírez JD; Bastard P; Gervais A; Bizien L; Casanova JL; Camacho B; Gallo JE; Gómez O; Rojas-Villarraga A; Pérez CE; Manrique R; Mantilla RD; Anaya JM
    BMC Infect Dis; 2022 Jun; 22(1):575. PubMed ID: 35761219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical Trial.
    Menichetti F; Popoli P; Puopolo M; Spila Alegiani S; Tiseo G; Bartoloni A; De Socio GV; Luchi S; Blanc P; Puoti M; Toschi E; Massari M; Palmisano L; Marano G; Chiamenti M; Martinelli L; Franchi S; Pallotto C; Suardi LR; Luciani Pasqua B; Merli M; Fabiani P; Bertolucci L; Borchi B; Modica S; Moneta S; Marchetti G; d'Arminio Monforte A; Stoppini L; Ferracchiato N; Piconi S; Fabbri C; Beccastrini E; Saccardi R; Giacometti A; Esperti S; Pierotti P; Bernini L; Bianco C; Benedetti S; Lanzi A; Bonfanti P; Massari M; Sani S; Saracino A; Castagna A; Trabace L; Lanza M; Focosi D; Mazzoni A; Pistello M; Falcone M;
    JAMA Netw Open; 2021 Nov; 4(11):e2136246. PubMed ID: 34842924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
    Kim MS; An MH; Kim WJ; Hwang TH
    PLoS Med; 2020 Dec; 17(12):e1003501. PubMed ID: 33378357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial.
    Diago-Sempere E; Bueno JL; Sancho-López A; Rubio EM; Torres F; de Molina RM; Fernández-Cruz A; de Diego IS; Velasco-Iglesias A; Payares-Herrera C; Flecha IC; Avendaño-Solà C; Palomino RD; Ramos-Martínez A; Ruiz-Antorán B
    Trials; 2021 Jan; 22(1):70. PubMed ID: 33472681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patients.
    Weisser M; Khanna N; Hedstueck A; Sutter ST; Roesch S; Stehle G; Sava M; Deigendesch N; Battegay M; Infanti L; Holbro A; Bassetti S; Pargger H; Hirsch HH; Leuzinger K; Kaiser L; Vu DL; Baur K; Massaro N; Busch MP; Simmons G; Stone M; Felgner PL; de Assis RR; Khan S; Tsai CT; Robinson PV; Seftel D; Irsch J; Bagri A; Buser AS; Corash L
    Transfusion; 2022 Oct; 62(10):1997-2011. PubMed ID: 36054476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of convalescent plasma transfusion on outcomes of coronavirus disease 2019: a meta-analysis with trial sequential analysis.
    Hakim SM; Chikhouni GMA; Ammar MA; Amer AM
    J Anesth; 2023 Jun; 37(3):451-464. PubMed ID: 36811668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19.
    Bandopadhyay P; D'Rozario R; Lahiri A; Sarif J; Ray Y; Paul SR; Roy R; Maiti R; Chaudhuri K; Bagchi S; Maiti A; Perwez MM; Sarkar BS; Roy D; Chakraborty R; Vasudevan JS; Sharma S; Biswas D; Maiti C; Saha B; Bhattacharya P; Pandey R; Chatterjee S; Paul S; Ganguly D
    J Infect Dis; 2021 Aug; 224(4):565-574. PubMed ID: 34398242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment.
    Ouyang J; Isnard S; Lin J; Fombuena B; Peng X; Routy JP; Chen Y
    Front Immunol; 2020; 11():570063. PubMed ID: 33072111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Convalescent Plasma Therapy in the management of COVID-19 patients-The newer dimensions.
    Mahapatra S; Rattan R; Mohanty CBK
    Transfus Clin Biol; 2021 Aug; 28(3):246-253. PubMed ID: 33965621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial.
    Bennett-Guerrero E; Romeiser JL; Talbot LR; Ahmed T; Mamone LJ; Singh SM; Hearing JC; Salman H; Holiprosad DD; Freedenberg AT; Carter JA; Browne NJ; Cosgrove ME; Shevik ME; Generale LM; Andrew MA; Nachman S; Fries BC; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Crit Care Med; 2021 Jul; 49(7):1015-1025. PubMed ID: 33870923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Convalescent Plasma and Tocilizumab in the Management of COVID-19 Infection: A Cohort of 110 Patients from a Tertiary Care Hospital in Oman.
    Khamis F; Memish Z; Al Bahrani M; Al Nummani H; Al Raisi D; Al Dowaiki S; Chhetri S; Al Fahdi F; Al Yahyai M; Pandak N; Al Bolushi Z; Alarimi Z; Al Hashmi S; Al Salmi I; Al-Zakwani I
    J Epidemiol Glob Health; 2021 Jun; 11(2):216-223. PubMed ID: 33605108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convalescent plasma treatment of critically ill intensive care COVID-19 patients.
    Lindemann M; Lenz V; Knop D; Klump H; Alt M; Aufderhorst UW; Schipper L; Schwarzkopf S; Meller L; Steckel N; Koldehoff M; Heinold A; Heinemann FM; Fischer J; Hutschenreuter G; Knabbe C; Dolff S; Brenner T; Dittmer U; Witzke O; Herbstreit F; Horn PA; Krawczyk A
    Transfusion; 2021 May; 61(5):1394-1403. PubMed ID: 33784412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Convalescent Plasma for High-Risk Outpatients with Covid-19.
    Korley FK; Durkalski-Mauldin V; Yeatts SD; Schulman K; Davenport RD; Dumont LJ; El Kassar N; Foster LD; Hah JM; Jaiswal S; Kaplan A; Lowell E; McDyer JF; Quinn J; Triulzi DJ; Van Huysen C; Stevenson VLW; Yadav K; Jones CW; Kea B; Burnett A; Reynolds JC; Greineder CF; Haas NL; Beiser DG; Silbergleit R; Barsan W; Callaway CW;
    N Engl J Med; 2021 Nov; 385(21):1951-1960. PubMed ID: 34407339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons learned from early compassionate use of convalescent plasma on critically ill patients with Covid-19.
    Liu M; Chen Z; Dai MY; Yang JH; Chen XB; Chen D; You H; Guo X; Leng Y; Yu L; Zhang ML; Wu X; Yang J; Gao C; Tenen DG; Chai L; Ai F
    Transfusion; 2020 Oct; 60(10):2210-2216. PubMed ID: 32770691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program.
    Wendel S; Kutner JM; Machado R; Fontão-Wendel R; Bub C; Fachini R; Yokoyama A; Candelaria G; Sakashita A; Achkar R; Hamerschlak N; Scuracchio P; Amaral M; Dal Ben M; Araujo D; Soares C; Camargo A; Kallás E; Durigon E; Reis LF; Rizzo LV
    Transfusion; 2020 Dec; 60(12):2938-2951. PubMed ID: 32935877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.